T0	Participants 80 115	contemporary coronary stent trials:
T1	Participants 288 326	The Resolute 'All-Comers' stent trial.
T2	Participants 486 556	after the assigned percutaneous coronary intervention or at discharge.
T3	Participants 692 766	2121/2292 patients (92.5%) had an analysable dataset for either biomarker.
T4	Participants 767 784	890/2121 patients
T5	Participants 840 856	267/890 patients